Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1992 Sep;66(3):503–506. doi: 10.1038/bjc.1992.303

Classical oestrogen receptor is not detectable in pancreatic adenocarcinoma.

O M Taylor 1, J Teasdale 1, P N Cowen 1, M J McMahon 1, E A Benson 1
PMCID: PMC1977934  PMID: 1520587

Abstract

Recent reports have suggested the presence of oestrogen receptors (ER) in pancreatic carcinoma. Therefore the tumour may be sensitive to hormone manipulation therapy. We examined 23 biopsies of human pancreatic carcinoma tissue for the presence of ER. The tissue was assayed by two methods: Iso-electric focusing (IEF) and ER-ICA an immunocytochemical assay. All biopsies were tested with ER-ICA and ten by IEF. Each biopsy was assessed histologically for tumour content and 20 contained adenocarcinoma. None of the samples of pancreatic carcinoma were positive for ER using the ER-ICA, and none demonstrated the binding peak typical of ER in the IEF assay. These results suggest that in pancreatic carcinoma oestrogen receptor is either absent (or at very low levels), or of a different type to that found in breast and uterine tissue. On theoretical grounds at least, this must raise questions as to the oestrogen sensitivity of pancreatic cancer.

Full text

PDF
503

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakkevold K. E., Pettersen A., Arnesjø B., Espehaug B. Tamoxifen therapy in unresectable adenocarcinoma of the pancreas and the papilla of Vater. Br J Surg. 1990 Jul;77(7):725–730. doi: 10.1002/bjs.1800770704. [DOI] [PubMed] [Google Scholar]
  2. Benz C., Hollander C., Miller B. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines. Cancer Res. 1986 May;46(5):2276–2281. [PubMed] [Google Scholar]
  3. Boctor A. M., Band P., Grossman A. Analysis of binding of [3H]Estradiol to the cytosol fraction of rat pancreas: comparison with sites in the cytosol of uterus. Endocrinology. 1983 Aug;113(2):453–462. doi: 10.1210/endo-113-2-453. [DOI] [PubMed] [Google Scholar]
  4. Boctor A. M., Band P., Grossman A. Specific binding of 3H-estradiol to the cytosol of rat pancreas and uterus: bound sites in pancreatic extracts do not translocate 3H-estradiol to nuclei suggesting a basic difference in mode of action. J Recept Res. 1981;2(5-6):453–463. doi: 10.3109/107998981809038878. [DOI] [PubMed] [Google Scholar]
  5. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  6. Charpin C., Martin P. M., Jacquemier J., Lavaut M. N., Pourreau-Schneider N., Toga M. Estrogen receptor immunocytochemical assay (ER-ICA): computerized image analysis system, immunoelectron microscopy, and comparisons with estradiol binding assays in 115 breast carcinomas. Cancer Res. 1986 Aug;46(8 Suppl):4271s–4277s. [PubMed] [Google Scholar]
  7. Davidoff F., Tishler S., Rosoff C. Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy. N Engl J Med. 1973 Sep 13;289(11):552–555. doi: 10.1056/NEJM197309132891103. [DOI] [PubMed] [Google Scholar]
  8. DeSombre E. R., Thorpe S. M., Rose C., Blough R. R., Andersen K. W., Rasmussen B. B., King W. J. Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancer. Cancer Res. 1986 Aug;46(8 Suppl):4256s–4264s. [PubMed] [Google Scholar]
  9. Fernö M., Borg A., Norgren A. A comparison of two steroid receptor assays in breast cancer: dextran coated charcoal and isoelectric focusing. Anticancer Res. 1983 Jul-Aug;3(4):243–246. [PubMed] [Google Scholar]
  10. Glueck C. J., Scheel D., Fishback J., Steiner P. Estrogen-induced pancreatitis in patients with previously covert familial type V hyperlipoproteinemia. Metabolism. 1972 Jul;21(7):657–666. doi: 10.1016/0026-0495(72)90089-3. [DOI] [PubMed] [Google Scholar]
  11. Greenway B., Iqbal M. J., Johnson P. J., Williams R. Oestrogen receptor proteins in malignant and fetal pancreas. Br Med J (Clin Res Ed) 1981 Sep 19;283(6294):751–753. doi: 10.1136/bmj.283.6294.751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Grossman A., Boctor A. M., Lane B. Dependence of pancreatic integrity on adrenal and ovarian secretions. Endocrinology. 1969 Nov;85(5):956–959. doi: 10.1210/endo-85-5-956. [DOI] [PubMed] [Google Scholar]
  13. Gustafsson J. A., Gustafsson S. A., Nordenskjöld B., Okret S., Silfverswärd C., Wrange O. Estradiol receptor analysis in human breast cancer tissue by isoelectric focusing in polyacrylamide gel. Cancer Res. 1978 Nov;38(11 Pt 2):4225–4228. [PubMed] [Google Scholar]
  14. Hawkins R. A., Sangster K., Krajewski A. Histochemical detection of oestrogen receptors in breast carcinoma: a successful technique. Br J Cancer. 1986 Mar;53(3):407–410. doi: 10.1038/bjc.1986.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Jackson P., Teasdale J., Cowen P. N. Development and validation of a sensitive immunohistochemical oestrogen receptor assay for use on archival breast cancer tissue. Histochemistry. 1989;92(2):149–152. doi: 10.1007/BF00490235. [DOI] [PubMed] [Google Scholar]
  16. Johnson H., Jr, Mir R., Richer S., Wise L. A comparative study of cytologic smears and frozen-tissue sections in the determination of sex steroid receptor status of breast carcinomas. Surgery. 1987 Oct;102(4):628–634. [PubMed] [Google Scholar]
  17. Jonat W., Maass H., Stegner H. E. Immunohistochemical measurement of estrogen receptors in breast cancer tissue samples. Cancer Res. 1986 Aug;46(8 Suppl):4296s–4298s. [PubMed] [Google Scholar]
  18. Keating J. J., Johnson P. J., Cochrane A. M., Gazzard B. G., Krasner N., Smith P. M., Trewby P. N., Wheeler P., Wilkinson S. P., Williams R. A prospective randomised controlled trial of tamoxifen and cyproterone acetate in pancreatic carcinoma. Br J Cancer. 1989 Nov;60(5):789–792. doi: 10.1038/bjc.1989.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. McCarty K. S., Jr, Szabo E., Flowers J. L., Cox E. B., Leight G. S., Miller L., Konrath J., Soper J. T., Budwit D. A., Creasman W. T. Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res. 1986 Aug;46(8 Suppl):4244s–4248s. [PubMed] [Google Scholar]
  20. McClelland R. A., Berger U., Miller L. S., Powles T. J., Jensen E. V., Coombes R. C. Immunocytochemical assay for estrogen receptor: relationship to outcome of therapy in patients with advanced breast cancer. Cancer Res. 1986 Aug;46(8 Suppl):4241s–4243s. [PubMed] [Google Scholar]
  21. Pousette A., Carlström K., Sköldefors H., Wilking N., Theve N. O. Purification and partial characterization of a 17 beta-estradiol-binding macromolecule in the human pancreas. Cancer Res. 1982 Feb;42(2):633–637. [PubMed] [Google Scholar]
  22. Rosenthal H. E., Sandberg A. A. Estrogen binding proteins in rat pancreas. J Steroid Biochem. 1978 Nov;9(11):1133–1139. doi: 10.1016/0022-4731(78)90044-4. [DOI] [PubMed] [Google Scholar]
  23. Sandberg A. A., Kirdani R. Y., Varkarakis M. J., Murphy G. P. Estrogen receptor protein of pancreas. Steroids. 1973 Aug;22(2):259–271. doi: 10.1016/0039-128x(73)90090-1. [DOI] [PubMed] [Google Scholar]
  24. Sandberg A. A., Rosenthal H. E. Steroid receptors in exocrine glands: the pancreas and prostate. J Steroid Biochem. 1979 Jul;11(1A):293–299. doi: 10.1016/0022-4731(79)90311-x. [DOI] [PubMed] [Google Scholar]
  25. Satake K., Yoshimoto T., Mukai R., Umeyama K. Estrogen receptors in 7,12-dimethylbenz (a) anthracene (DMBA) induced pancreatic carcinoma in rats and in human pancreatic carcinoma. Clin Oncol. 1982 Mar;8(1):49–54. [PubMed] [Google Scholar]
  26. Stedman K. E., Moore G. E., Morgan R. T. Estrogen receptor proteins in diverse human tumors. Arch Surg. 1980 Mar;115(3):244–248. doi: 10.1001/archsurg.1980.01380030004002. [DOI] [PubMed] [Google Scholar]
  27. Theve N. O., Pousette A., Carlström K. Adenocarcinoma of the pancreas--a hormone sensitive tumor? A preliminary report on Nolvadex treatment. Clin Oncol. 1983 Sep;9(3):193–197. [PubMed] [Google Scholar]
  28. Tønnesen K., Kamp-Jensen M. Antiestrogen therapy in pancreatic carcinoma: a preliminary report. Eur J Surg Oncol. 1986 Mar;12(1):69–70. [PubMed] [Google Scholar]
  29. ULLBERG S., BENGTSSON G. Autoradiographic distribution studies with natural oestrogens. Acta Endocrinol (Copenh) 1963 May;43:75–86. doi: 10.1530/acta.0.0430075. [DOI] [PubMed] [Google Scholar]
  30. Underwood J. C., Dangerfield V. J., Parsons M. A. Oestrogen receptor assay of cryostat sections of human breast carcinomas with simultaneous quantitative histology. J Clin Pathol. 1983 Apr;36(4):399–405. doi: 10.1136/jcp.36.4.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Wrange O., Nordenskjöld B., Silfverswärd C., Granberg P. O., Gustafsson J. A. Isoelectric focusing of estradiol receptor protein from human mammary carcinoma - a comparison to sucrose gradient analysis. Eur J Cancer. 1976 Sep;12(9):695–700. doi: 10.1016/0014-2964(76)90018-9. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES